Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • On Demand
  • Prologue: Using Potency Readouts to Establish Critical Quality Attributes and Inform Vector Characterization Priorities
    Prologue Speaker: Hangtian Song, PhD – Bristol-Myers Squibb Company
    Manufacturing & Analytical Characterization
  • Prologue:  Applying Machine Learning to the Laboratory: How AI Can Help Us Innovate
    Prologue Speaker: Vibha Jawa, PhD FAAPS (she/her/hers) – Bristol Myers Squibb
    Bioanalytics
  • Prologue:  Challenges in Bioanalysis
    Prologue Speaker: Catherine Vrentas, PhD, MBA, MPH (she/her/hers) – Booz Allen Hamilton
    Bioanalytics
  • Prologue:  Regulatory Implications: From Immunogenicity to Diagnostics
    Prologue Speaker: Mohsen Rajabi, Ph.D. – US Food and Drug Administration
    Bioanalytics
  • Prologue:  Understanding HRMS in Regulated Bioanalysis, with Applications for ADCs
    Prologue Speaker: William R. Mylott, Jr., BS Chemistry – Thermo Fisher Scientific
    Bioanalytics
  • Prologue: Big Data Approaches to Understanding Particle Properties
    Prologue Speaker: Mike Tobyn, PhD (he/him/his) – Bristol Myers Squibb
    Manufacturing & Analytical Characterization
  • Prologue: Biomarker Strategies in Therapeutics Development for Rare Diseases
    Prologue Speaker: Yow-Ming Wang, PhD – US Food and Drug Administration
    Preclinical, Clinical and Translational Sciences
  • Prologue: Biomarkers as Linkers Between Preclinical, Clinical, and Patient Outcome
    Prologue Speaker: Matt D. Harwood, MSc, PhD – Certara UK (Simcyp Division)
    Preclinical, Clinical and Translational Sciences
  • Prologue: Can We Deliver Macro Peptides Orally?
    Prologue Speaker: Jenna Walker, PhD – Eli Lilly
    Formulation and Delivery
  • Prologue: Employing Machine Learning to Image, Quantify, and Predict Pharmacokinetics to Support Drug Development
    Prologue Speaker: Conor Evans, PhD – Massachusetts General Hospital / Harvard Medical School
    Preclinical, Clinical and Translational Sciences
  • Prologue: Flexible Manufacturing at Merck
    Prologue Speaker: Anna Jenks (she/her/hers) – Merck & Co., Inc. - Rahway NJ
    Manufacturing & Analytical Characterization
  • Prologue: High Dose Subcutaneous Delivery of Protein Therapeutics
    Prologue Speaker: Erica Schlesinger, PhD (she/her/hers) – Seran Biosciences, LLC
    Formulation and Delivery
  • Prologue: Integrated in vitro-in silico Approach in Clinical Drug Development
    Prologue Speaker: Siddhi S. Hate, PhD – Eli Lilly and Company
    Formulation and Delivery
  • Prologue: LNP's: Formulations that Pushed Back COVID-19
    Prologue Speaker: Rajiv Nayar, PhD – HTD Biosystems Inc.
    Manufacturing & Analytical Characterization
  • Prologue: Mechanistic Models in Manufacturing
    Prologue Speaker: Indrajit Jagtap (he/him/his) – Intelimek LLC
    Manufacturing & Analytical Characterization
  • Prologue: Methods to Assess the Targeted Brain Drug Delivery in Preclinical Settings
    Prologue Speaker: Irena Loryan, MD, PhD (she/her/hers) – Uppsala University
    Discovery and Basic Research
  • Prologue: Prospects and Challenges of Cell Selective Liposome for the Treatment of Auto-Immune Diseases
    Prologue Speaker: Md Nurunnabi, PhD – University of Mississippi
    Discovery and Basic Research
  • Prologue: Regulatory Considerations for Continuous Manufacturing
    Prologue Speaker: Scott M. Krull, PhD (he/him/his) – US Food and Drug Administration
    Manufacturing & Analytical Characterization
  • Prologue: Regulatory Implications: from Immunogenicity to Diagnostics
    Prologue Speaker: Weifeng Xu, PhD – Merck & Co.
    Bioanalytics
  • Prologue: The Effect of Excipients on the Colloidal Stability of Monoclonal Antibodies
    Prologue Speaker: Stephen W. Hoag, PhD – University of Maryland Baltimore
    Formulation and Delivery
  • Prologue: Transforming Drug Development: Advanced Modeling and Virtual Data for Enhanced Trials
    Prologue Speaker: Vibha Jawa, PhD FAAPS (she/her/hers) – Bristol Myers Squibb
    Preclinical, Clinical and Translational Sciences
  • 12:00 PM – 1:00 PM MT
    Prologue: How Artificial Intelligence will Redefine the Roles of Scientific and Medical Writers
    Prologue Speaker: David Hauss, PhD, RPh – Hauss Associates LLC
    Discovery and Basic Research